Medicare beneficiaries who enroll in a $0-premium Medicare Advantage plan for 2026 could still face thousands of dollars in out-of-pocket costs if they are hospitalized or need specialist care. The Centers for Medicare & Medicaid Services (CMS) has published its official CY 2026 maximum out-of-pocket and cost-sharing limit calculations, setting the ceiling that plans can charge before full coverage begins. That ceiling, while required by federal regulation, sits well above zero, and Original Medicare offers no annual out-of-pocket limit at all unless a beneficiary carries supplemental coverage.
How $0-premium plans shift costs to sick enrollees
A monthly premium of $0 does not eliminate cost-sharing. Every Medicare Advantage plan must set an annual maximum out-of-pocket amount for Part A and Part B services, as required under 42 CFR Section 422.100. CMS publishes these annual MOOP limits as part of its Medicare Advantage rate statistics, and plans are free to set their caps anywhere up to that published ceiling. The result: a beneficiary paying nothing each month can still owe copays and coinsurance on every hospital day, every specialist visit, and every outpatient procedure until hitting a cap that can run into several thousand dollars.
The gap between premium cost and actual cost grows sharply during a serious illness. A cancer diagnosis requiring surgery, chemotherapy, and imaging can generate bills that push a patient toward the plan’s MOOP within weeks. Cardiac events requiring catheterization or bypass surgery carry similar exposure. Until the annual cap is reached, the enrollee pays a share of each service, and those shares add up fast. Enrollees who rarely use care may see little of this cost-sharing, but people with multiple chronic conditions or sudden acute events are more likely to collide with the upper limits of their plan’s design.
Plan marketing materials often emphasize extras such as dental, vision, or gym benefits that come bundled with a $0 premium. Those add-ons can be valuable, but they do not change the underlying medical cost-sharing rules. A low or zero premium simply shifts more of the financial risk from the insurer to the enrollee at the point of service. Understanding the MOOP figure, and the copay schedule that leads up to it, is essential for anyone comparing plans based on more than just the monthly bill.
Separate drug costs and the $2,100 Part D threshold
Medical cost-sharing under Parts A and B is only one layer. Prescription drug expenses fall under a separate structure. CMS set the CY 2026 Part D out-of-pocket threshold at $2,100, according to the agency’s Advance Notice fact sheet. That cap applies specifically to drug spending and governs when a beneficiary reaches the catastrophic phase of Part D coverage, not when hospital or physician bills stop accumulating.
A beneficiary battling a serious illness often faces both categories at once. Someone undergoing cancer treatment, for example, may pay coinsurance on chemotherapy infusions billed under Part B, copays for hospital stays under Part A, and separate cost-sharing for oral medications under Part D. The medical MOOP and the Part D threshold represent two distinct pools of potential spending, each with its own rules and limits. Hitting the drug threshold does not erase medical copays, and reaching the medical MOOP does not automatically eliminate cost-sharing on prescriptions that fall under Part D’s design.
Conflating the two is a common mistake during plan selection. A plan summary might highlight a $0 premium and a drug-cost cap, but the medical side carries its own copays and coinsurance schedule that only stops accumulating once the separate MOOP is hit. Beneficiaries comparing options need to review both the medical and drug benefit charts to understand their total exposure in a high-use year.
Original Medicare offers no annual spending cap
Beneficiaries weighing their options should also understand the alternative. CMS consumer cost guidance explains that Original Medicare has no yearly out-of-pocket limit unless a beneficiary adds supplemental coverage such as a Medigap policy. Under traditional fee-for-service Medicare, Part A deductibles and coinsurance can recur with multiple hospitalizations, and the standard 20 percent coinsurance on most Part B services continues indefinitely, with no built-in annual ceiling.
Medicare Advantage plans, by contrast, are legally required to cap annual exposure for Part A and Part B services, but that cap can still represent a significant financial burden for someone on a fixed income. A person who values predictable worst-case costs may prefer a Medicare Advantage plan with a lower MOOP, even if it comes with a modest premium, while someone who purchases a robust Medigap policy alongside Original Medicare can effectively create their own form of spending limit through supplemental protection.
For 2026, the policy landscape underscores a central trade-off: $0-premium Medicare Advantage coverage does not mean $0 risk. Between the federally defined MOOP for medical services, the separate $2,100 Part D threshold for prescription drugs, and the absence of any automatic cap in Original Medicare, beneficiaries must look beyond premiums and extras to gauge how much they could pay in a bad health year. Careful review of plan documents, including MOOP levels and drug benefit structures, can help enrollees choose coverage that aligns with both their health needs and their tolerance for financial uncertainty.
Free for readers: The free Retirement Shield newsletter sends plain-English help keeping more of your money in retirement — the scams to dodge, the benefits you’re owed, and what’s changing with Social Security and Medicare, a couple times a week. Get the free newsletter.
Warren Cohen is a finance writer based in Phoenix, Arizona, covering personal finance topics including credit, banking, and beginner investing. He earned his degree in business administration from Arizona State University and began his career working in consumer finance, where he gained direct experience with lending and credit systems. He now writes for personal finance websites and fintech platforms, focusing on clear, practical content that helps readers make informed financial decisions.
